Kufe D W, Wick M M, Abelson H T
J Invest Dermatol. 1980 Oct;75(4):357-9. doi: 10.1111/1523-1747.ep12531146.
Human melanomas are naturally resistant to methotrexate (MTX). The mechanism of intrinsic drug resistance has been explored in 3 melanoma cell lines not previously exposed to this agent. All 3 lines exhibited relative MTX resistance with ID50 values of greater than 1 microM. Drug uptake studies were performed over an extracellular concentration range of 0.1 to 10 microM MTX. The uptake was linear over the initial 10 min at all concentrations and subsequently reached plateau levels only at the 10 microM concentration. Lineweaver-Burke transformations yielded apparent Km (uptake) values of 1.4 to 5 microM, similar to data obtained from other human cell lines. The level of dihydrofolate reductase (DHFR) in the human melanoma cells ranged between 8.42 to 11.98 pmoles/mg protein. The melanoma DHFR levels are several fold higher than in MTX-sensitive human tumor lines and up to a hundred-fold higher than that measured in human brain tumor cells by our assay. The intrinsic resistance of these melanoma lines has therefore been attributed to elevated intracellular levels of DHFR.
人类黑色素瘤对甲氨蝶呤(MTX)天然耐药。在3种此前未接触过该药物的黑色素瘤细胞系中探究了内在耐药机制。所有3种细胞系均表现出对MTX的相对耐药性,半数抑制浓度(ID50)值大于1微摩尔。在0.1至10微摩尔MTX的细胞外浓度范围内进行了药物摄取研究。在所有浓度下,最初10分钟内摄取呈线性,随后仅在10微摩尔浓度时达到平台期水平。Lineweaver-Burke转换得出的表观米氏常数(摄取)值为1.4至5微摩尔,与从其他人类细胞系获得的数据相似。人类黑色素瘤细胞中二氢叶酸还原酶(DHFR)的水平在8.42至11.98皮摩尔/毫克蛋白质之间。黑色素瘤的DHFR水平比MTX敏感的人类肿瘤细胞系高几倍,比我们测定的人类脑肿瘤细胞中的水平高出多达一百倍。因此,这些黑色素瘤细胞系的内在耐药性归因于细胞内DHFR水平的升高。